Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

October 9, 2025 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has developed a new series of orally active, non-covalent protease inhibitors with dose-dependent antiviral activity in mice infected with SARS Coronavirus (SARS-CoV-2). This work was carried out at the University of Arizona as...

Read more

Sensi.AI Raises $45M Series C, Extending Its Dominance of Care Intelligence in Vertical AI

October 9, 2025 8:00 AM

Sensi.AI, the pioneer in Care Intelligence, today announced a $45 million Series C funding round led by Qumra Capital with continued support from existing investors Zeev Ventures, Insight Partners, Entrée Capital, Flint Capital, and Jibe Ventures. This latest raise brings the company's total funding to over $98 million, and will fuel its mission to close the massive care gap in aging.The world is entering a historic aging crisis. By 2030, one in...

Read more

AMC Health Appoints Alan Petrazzi as Executive Vice President, Government Division

October 9, 2025 8:00 AM

AMC Health, a leading provider of virtual care and remote patient monitoring solutions, today announced the appointment of Alan Petrazzi as Executive Vice President, Government Division, and the latest member of the company's growing Executive Leadership Team.In this critical role, Petrazzi will develop, lead, and execute AMC Health's comprehensive government strategy, driving growth across federal, state, and local government sectors. He will...

Read more

Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies

October 9, 2025 8:00 AM

Behind every healthy pet is a founder bold enough to build what doesn't yet exist.Today, Pawsible Ventures announces the launch of a $10 million venture fund and studio dedicated to reimagining how we care for animals, by backing and building the next generation of companies transforming the $250B+ global pet health and wellness market.As pet spending now surpasses baby spending in many households, the world's bond with animals has never been...

Read more

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells

October 9, 2025 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced new findings demonstrating that Telomir-1 significantly decreases the viability of aggressive triple-negative breast cancer (TNBC) cells - a highly invasive form of breast cancer that lacks hormone and HER2 receptors,...

Read more

Bausch Health Announces Results of Special Meeting of Shareholders

October 9, 2025 7:00 AM

Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation and approval of the adoption of the Company's Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025...

Read more

Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar

October 9, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its upcoming "Fourth Friday at Four" webinar series, to be held on October 24, 2025 at 4:00 p.m. ET, will feature a deep dive into Zomedica's VETGuardian Zero Touch monitoring platform.Key Learning PointsMarket Expansion...

Read more

EX DEA Administrator Anne Milgram's "Swampy" Legacy: No-Bid Contracts, No Marijuana Reform, and No Accountability

October 9, 2025 5:00 AM

Former DEA Administrator Anne Milgram left behind a cloud of controversy, unanswered questions, and a legacy of paralysis on medical marijuana policy. As new details emerge about the potential Justice Department Inspector General's investigation into her administration's no-bid contracts to friends and former colleagues, one thing is unmistakably clear: under Milgram's leadership, the DEA squandered historic opportunities to modernize its...

Read more

Direct by Syndicate Bio Launches to Power AI-Enabled Precision Medicine in Nigeria

October 9, 2025 4:00 AM

Syndicate Bio today announced the launch of Direct by Syndicate Bio, a comprehensive genetic testing and precision medicine service designed to deliver actionable insights to patients, providers, and consumers across Africa. The launch coincides with the opening of a state-of-the-art sequencing laboratory in Lagos, enabling world-class genomic and multi-omics testing powered by AI-delivered locally for Nigeria's 200 million citizens and the...

Read more

Jacksonvilles Trusted Weight Loss and Aesthetics Clinic

October 9, 2025 3:40 AM

RSLV Aesthetics, a leading provider of non-invasive aesthetics and wellness treatments, has officially launched Physician Guided Weight Loss by RSLV, a new medically supervised division designed to help clients achieve sustainable results through science-based programs that integrate medical weight management with advanced body contouring technology.Combining Medical Expertise and Aesthetic InnovationPhysician Guided Weight Loss by RSLV offers...

Read more

BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis

October 9, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, today announced that it has completed a Track One priority patent filing with the U.S. Patent and Trademark Office (USPTO) for its proprietary sublingual thin-film cladribine formulation (BNT23001), designed for the treatment of multiple sclerosis (MS). The Track One patent filing...

Read more

Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification

October 9, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), announces that its board of directors has taken the decision to terminate, and not to proceed with, the subscription announced by the Company on 2 October 2025 (the "Initial Transaction"). Please see Issue of Equity - Correction - 12:37:10 02 Oct 2025 - GENF News article | London Stock Exchange.In the alternative, it has raised gross proceeds of £440,000 (before...

Read more

IRLAB to Present at Redeye Theme: Neurology

October 9, 2025 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that CEO Kristina Torfgård will present IRLAB at Redeye Theme: Neurology on October 15 in Stockholm.Both Swedish and international investors will participate in the meeting, providing the company with excellent opportunities to expand its network and...

Read more

Peek Healthcare Technologies, Inc. ('Peek') Launches Direct-to-Employer and Direct-to-Patient Pricing for IMULDOSA(R) (ustekinumab-srlf) (Stelara(R) Biosimilar)

October 8, 2025 12:00 PM

Peek, a leading healthcare technology company, today announced the launch of PeekDirect™ pricing for IMULDOSA® (ustekinumab-srlf), a biosimilar to Stelara® (ustekinumab), delivering transparent and dramatically lower costs to employers and patients.Effective immediately, IMULDOSA will be available through the Peek Meds Marketplace.This direct model bypasses the traditional rebate-driven pricing system, ensuring employers and patients benefit...

Read more

Mobility: The New Measure of Aging

October 8, 2025 11:45 AM

Most of us associate getting older with complications and issues. These problems seem unavoidable and just a natural part of aging. However, as more and more research comes out about mobility, it's becoming clear that mobility, rather than chronological age, is the new measure of aging."Mobility is a new predictor of aging," said Sheewayne Sandoval, CEO of BenCura Rehabilitation Services. "The more mobile you are, the less likely you are to have...

Read more

Dr. Jennifer Robinson Calls for Greater Access to Mental Health Care

October 8, 2025 10:15 AM

Dr. Jennifer Robinson, a board-certified psychiatrist and Director of Psychiatric Services at Integral Psychiatric and Recovery Services, is raising awareness about the need for greater accessibility in mental health care. Drawing on more than a decade of experience in hospitals, recovery centers, and telehealth, she emphasizes that the most powerful step begins at home-with individuals seeking help."Helping others improve their mental health...

Read more

Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections

October 8, 2025 10:15 AM

Belhaven Biopharma, a leader in developing innovative intranasal products for emergency use, today announced that the U.S. Food and Drug Administration ("FDA" or the "Agency") has accepted their IND application for Nasdepi® (BBP01), a novel, investigational nasal powder epinephrine formulation, designed as a needle-free alternative for the emergency treatment of anaphylaxis. This key milestone marks the next step in Nasdepi's development,...

Read more

Duly Health and Care Physicians Now Offering Access to Galleri(R) Multi-Cancer Early Detection Test

October 8, 2025 10:00 AM

Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, LTD., is now offering access to the Galleri® multi-cancer early detection (MCED) test, a groundbreaking tool designed to screen for a signal shared by more than 50 types of cancer -- many of which currently have no recommended screening tests.Finding cancer early can provide more treatment options and improve the potential for better outcomes. While traditional...

Read more

Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules

October 8, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in AI-powered preventive healthcare, announced that it is preparing to conduct internal, non-clinical research studies on the consumer-facing components of its AI health platform - the Mental Health & Micro-Expression Tracker and the Preventive Health & Facial Biometrics Analyzer.These studies are part of the company's Consumer AI Division, which focuses on self-monitoring,...

Read more

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

October 8, 2025 8:20 AM

Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology company developing novel bispecific and trispecific immuno-oncology therapeutics, today announced its participation in upcoming key financial, industry, scientific and medical conferences this fall, providing the opportunity to highlight continued momentum and recent developments among a broad range of stakeholder audiences.These conferences include:4th...

Read more